Materials • Major Chemicals
$3.69 ▼ -0.03
(-0.81%)
MKT CAP: $589.3M • VOL: 2.49M
52W L $3 52W H $11
TROX // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.90B | $3.07B | $2.85B |
| YoY Revenue Growth % | -5.7% | +7.9% | — |
| Gross Profit | $269.0M | $515.0M | — |
| Gross Margin % | 9.3% | 16.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$253.0M | $219.0M | $186.0M |
| Operating Margin % | -8.7% | 7.1% | 6.5% |
| Net Income (GAAP) | -$470.0M | -$48.0M | -$316.0M |
| EBITDA (Normalized) | — | — | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $60.0M | $300.0M | $184.0M |
| Capital Expenditures (CapEx) | — | — | — |
| Free Cash Flow (FCF) | $60.0M | $300.0M | $184.0M |
| FCF Margin % | 2.1% | 9.8% | 6.5% |
| Return on Invested Capital (ROIC %) | -16.4% | 10.7% | — |
| Cash & Short-Term Equivalents | $199.0M | $151.0M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.42B | $1.76B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR TROX.